UPDATED Mar 18, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$417.32 | 3.2% | 53.3% | US$3.1t | US$465.34 | PE37.6x | E12.4% | 0.7% | Software | ||
AAPL | US$173.72 | 0.6% | 10.4% | US$2.7t | US$200.53 | PE26.6x | E4.8% | 0.6% | Tech | ||
GOOGL | US$147.68 | 7.3% | 45.9% | US$1.8t | US$164.06 | PE24.9x | E11.8% | n/a | Media | ||
AMZN | US$174.48 | 1.5% | 78.6% | US$1.8t | US$204.98 | PE59.6x | E21.7% | n/a | Retail | ||
META | US$496.98 | 2.8% | 151.2% | US$1.3t | US$518.26 | PE32.4x | E14.2% | 0.4% | Media | ||
LLY | US$762.66 | 3.9% | 128.6% | US$686.5b | US$790.49 | PE131x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
AVGO | US$1,237.24 | -4.3% | 92.2% | US$573.4b | US$1,497.67 | PE49.5x | E23.2% | 1.7% | Semiconductors | ||
JPM | US$192.66 | 2.3% | 51.5% | US$554.9b | US$194.90 | PB1.8x | E-1.9% | 2.2% | Banks | ||
WMT | US$60.86 | 0.3% | 29.6% | US$490.4b | US$65.35 | PE31.6x | E10.5% | 1.4% | Consumer Retailing | ||
UNH | US$487.05 | -0.4% | 2.1% | US$449.0b | US$590.60 | PE20.1x | E9.7% | 1.5% | Healthcare | ||
XOM | US$112.30 | 3.0% | 9.6% | US$445.6b | US$123.54 | PE12.4x | E-1.3% | 3.4% | Energy | ||
PG | US$161.21 | -0.2% | 11.1% | US$379.3b | US$168.99 | PE26.2x | E7.2% | 2.3% | Household | ||
JNJ | US$156.76 | -2.8% | 1.9% | US$377.8b | US$174.42 | PE28.3x | E9.7% | 3.0% | Pharmaceuticals & Biotech | ||
COST | US$731.54 | 2.4% | 49.5% | US$324.4b | US$747.56 | PE47.8x | E7.4% | 0.6% | Consumer Retailing | ||
ABBV | US$178.49 | -0.6% | 14.3% | US$315.3b | US$183.32 | PE65.4x | E23.5% | 3.5% | Pharmaceuticals & Biotech | ||
MRK | US$121.44 | -1.1% | 14.7% | US$307.6b | US$134.26 | PE842.6x | E24.1% | 2.5% | Pharmaceuticals & Biotech | ||
CRM | US$300.51 | -1.8% | 62.2% | US$291.5b | US$331.25 | PE70.5x | E18.7% | 0.5% | Software | ||
CVX | US$155.41 | 2.2% | 0.5% | US$288.6b | US$176.87 | PE13.5x | E0.6% | 4.2% | Energy | ||
BAC | US$36.01 | 0.3% | 29.8% | US$284.1b | US$37.89 | PB1.1x | E3.7% | 2.7% | Banks | ||
KO | US$60.13 | -0.2% | -0.8% | US$259.2b | US$65.97 | PE24.2x | E7.9% | 3.2% | Food, Beverage & Tobacco | ||
PEP | US$171.26 | 4.0% | -3.6% | US$235.4b | US$186.71 | PE25.9x | E9.3% | 3.0% | Food, Beverage & Tobacco | ||
ADBE | US$513.86 | -8.3% | 41.6% | US$232.5b | US$622.80 | PE48.4x | E17.0% | n/a | Software | ||
TMO | US$580.05 | -3.2% | 5.4% | US$221.2b | US$599.75 | PE36.9x | E10.5% | 0.3% | Pharmaceuticals & Biotech | ||
WFC | US$57.77 | 1.2% | 54.1% | US$206.7b | US$56.41 | PB1.2x | E2.2% | 2.4% | Banks |